Cargando…

Exploring Possible Diagnostic Precancerous Biomarkers for Oral Submucous Fibrosis: A Narrative Review

SIMPLE SUMMARY: Oral submucous fibrosis is a progressive oral disorder categorized as a potentially malignant condition. Researchers have identified specific molecular biomarkers associated with oral submucous fibrosis. The objective of our study was to conduct an up-to-date and comprehensive review...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Jie-Ru, Chen, Ya-Ting, Hsieh, Chia-Yu, Chen, Sin-Yu, Lin, Tzu-Yao, Shih, Jing-Syuan, Chen, Guan-Ting, Feng, Sheng-Wei, Peng, Tzu-Yu, Wu, Chia-Yu, Lee, I-Ta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571555/ https://www.ncbi.nlm.nih.gov/pubmed/37835505 http://dx.doi.org/10.3390/cancers15194812

Ejemplares similares

miR‐200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2
por: Liao, Yi‐Wen, et al.
Publicado: (2018)

Positive Feedback Loop of SNAIL-IL-6 Mediates Myofibroblastic Differentiation Activity in Precancerous Oral Submucous Fibrosis
por: Peng, Chih-Yu, et al.
Publicado: (2020)

Targeting lncRNA H19/miR-29b/COL1A1 Axis Impedes Myofibroblast Activities of Precancerous Oral Submucous Fibrosis
por: Yu, Cheng-Chia, et al.
Publicado: (2021)

The functional roles of microRNAs in the pathogenesis of oral submucous fibrosis
por: Hsieh, Pei-Ling, et al.
Publicado: (2022)

Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition
por: Lin, Ching-Yeh, et al.
Publicado: (2019)

MiR-424/TGIF2-Mediated Pro-Fibrogenic Responses in Oral Submucous Fibrosis
por: Chou, Ming-Yung, et al.
Publicado: (2023)

LINC00312/YBX1 Axis Regulates Myofibroblast Activities in Oral Submucous Fibrosis
por: Yu, Chuan-Hang, et al.
Publicado: (2020)

Photobiomodulation therapy inhibits oral submucous fibrosis in mice
por: Chiang, Min‐Hsuan, et al.
Publicado: (2020)

Aberrant SSEA-4 upregulation mediates myofibroblast activity to promote pre-cancerous oral submucous fibrosis
por: Yu, Cheng-Chia, et al.
Publicado: (2016)

Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy
por: Shih, Yin-Hwa, et al.
Publicado: (2019)

Elevation of S100A4 Expression in Buccal Mucosal Fibroblasts by Arecoline: Involvement in the Pathogenesis of Oral Submucous Fibrosis
por: Yu, Cheng-Chia, et al.
Publicado: (2013)

Fucoidan-Mediated Inhibition of Fibrotic Properties in Oral Submucous Fibrosis via the MEG3/miR-181a/Egr1 Axis
por: Fang, Chih-Yuan, et al.
Publicado: (2022)

Research Achievements of Oral Submucous Fibrosis: Progress and Prospect
por: Xu, Hui, et al.
Publicado: (2021)

M2 macrophage polarization modulates epithelial-mesenchymal transition in cisplatin-induced tubulointerstitial fibrosis
por: Yu, Chia-Cherng, et al.
Publicado: (2016)

Characterization of a Novel Dermal Fibrosis Model Induced by Areca Nut Extract that Mimics Oral Submucous Fibrosis
por: Chiang, Min-Hsuan, et al.
Publicado: (2016)

LINC00084/miR-204/ZEB1 Axis Mediates Myofibroblastic Differentiation Activity in Fibrotic Buccal Mucosa Fibroblasts: Therapeutic Target for Oral Submucous Fibrosis
por: Lee, Yu-Hsien, et al.
Publicado: (2021)

VEGF gene transfection restores the angiogenesis of oral submucous fibrosis in mice
por: Sun, Ying, et al.
Publicado: (2021)

Role of areca nut induced JNK/ATF2/Jun axis in the activation of TGF-β pathway in precancerous Oral Submucous Fibrosis
por: Pant, Ila, et al.
Publicado: (2016)

Drug treatment for oral submucous fibrosis: an update
por: Chen, Xueru, et al.
Publicado: (2023)

Tanshinone Suppresses Arecoline-Induced Epithelial–Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway
por: Zheng, Lian, et al.
Publicado: (2018)

Oral submucous fibrosis: an update
por: Wollina, Uwe, et al.
Publicado: (2015)

Oral submucous fibrosis: An update
por: Ray, Jay Gopal, et al.
Publicado: (2017)

Genetic Susceptibility and Protein Expression of Extracellular Matrix Turnover-Related Genes in Oral Submucous Fibrosis
por: Cheng, Ru-Hsiu, et al.
Publicado: (2020)

Lipid profile in oral submucous fibrosis
por: Mehrotra, Ravi, et al.
Publicado: (2009)

Medical management of oral submucous fibrosis
por: Shanbhag, Vagish Kumar Laxman
Publicado: (2015)

Prophage Excision in Streptococcus pneumoniae Serotype 19A ST320 Promote Colonization: Insight Into Its Evolution From the Ancestral Clone Taiwan 19F-14 (ST236)
por: Chen, Yi-Yin, et al.
Publicado: (2019)

Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan
por: Chen, Chia-Yu, et al.
Publicado: (2022)

Disruption of Lipid Raft Function Increases Expression and Secretion of Monocyte Chemoattractant Protein-1 in 3T3-L1 Adipocytes
por: Lu, Juu-Chin, et al.
Publicado: (2016)

A Possible Role of Insertion Sequence IS1216V in Dissemination of Multidrug-Resistant Elements MES(PM1) and MES(6272-2) between Enterococcus and ST59 Staphylococcus aureus
por: Lin, Yu-Tzu, et al.
Publicado: (2020)

Hematinic deficiencies and anemia in gastric parietal cell antibody-positive and -negative oral submucous fibrosis patients
por: Chiang, Chun-Pin, et al.
Publicado: (2018)

PTMA, a new identified autoantigen for oral submucous fibrosis, regulates oral submucous fibroblast proliferation and extracellular matrix
por: Wang, Jie, et al.
Publicado: (2017)

Allergic rhinitis is associated with thromboembolic disease in pregnancy
por: Wu, Chia-Ta, et al.
Publicado: (2022)

Management of Oral Submucous Fibrosis with Injection of Hyaluronidase and Dexamethasone in Grade III Oral Submucous Fibrosis: A Retrospective Study
por: James, Leena, et al.
Publicado: (2015)

Spiritual well‐being of patients with chronic renal failure: A cross‐sectional study
por: LI, Chia‐Yu, et al.
Publicado: (2021)

EZBite open-mouth device: A new treatment option for oral submucous fibrosis-related trismus
por: Li, Yu-Hsuan, et al.
Publicado: (2018)

Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments
por: Shen, Yen-Wen, et al.
Publicado: (2020)

Submucous fibrosis of the oral cavity. Histomorphological studies.
por: Wahi, P. N., et al.
Publicado: (1966)

Proliferation and apoptosis markers in oral submucous fibrosis
por: Ranganathan, K, et al.
Publicado: (2011)

Oral submucous fibrosis and its dermatological relation
por: Ali, Fareedi Mukram, et al.
Publicado: (2014)

Pathogenesis and therapeutic intervention of oral submucous fibrosis
por: Yoithapprabhunath, Thukanaykanpalayam Ragunathan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0njssc3ask4lh8u32hb3f40157